Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

666 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of NRAS mutations as prognostic and predictive markers in metastatic colorectal cancer.
Schirripa M, Cremolini C, Loupakis F, Morvillo M, Bergamo F, Zoratto F, Salvatore L, Antoniotti C, Marmorino F, Sensi E, Lupi C, Fontanini G, De Gregorio V, Giannini R, Basolo F, Masi G, Falcone A. Schirripa M, et al. Among authors: masi g. Int J Cancer. 2015 Jan 1;136(1):83-90. doi: 10.1002/ijc.28955. Epub 2014 May 28. Int J Cancer. 2015. PMID: 24806288
Protracted continuous infusion of 5-fluorouracil and low-dose leucovorin in patients with metastatic colorectal cancer resistant to 5-fluorouracil bolus-based chemotherapy: a phase II study.
Falcone A, Allegrini G, Lencioni M, Pfanner E, Brunetti I, Cianci C, Galli C, Masi G, Antonuzzo A, Conte P. Falcone A, et al. Among authors: masi g. Cancer Chemother Pharmacol. 1999;44(2):159-63. doi: 10.1007/s002800050961. Cancer Chemother Pharmacol. 1999. PMID: 10412951 Clinical Trial.
Oral doxifluridine in advanced hepatocellular carcinoma: A phase II study.
Lencioni M, Falcone A, Allegrini G, Pfanner E, Masi G, Brunetti I, Di Marsico R, Fontana E, Orlandini C, Stampino CG, Bartolozzi C, Conte PF. Lencioni M, et al. Among authors: masi g. Oncology. 2000 Sep;59(3):204-9. doi: 10.1159/000012162. Oncology. 2000. PMID: 11053987 Clinical Trial.
5-fluorouracil administered as a 48-hour semiintermittent infusion in combination with leucovorin, cisplatin and epirubicin: phase II study in advanced gastric cancer patients.
Allegrini G, Falcone A, Di Marsico R, Lencioni M, Masi G, Galli C, Cupini S, Pfanner E, Marcucci L, Conte PF. Allegrini G, et al. Among authors: masi g. Am J Clin Oncol. 2004 Feb;27(1):101-5. doi: 10.1097/01.coc.0000047128.73574.e6. Am J Clin Oncol. 2004. PMID: 14758142 Clinical Trial.
666 results